New research shows that in people with high blood pressure as part of metabolic syndrome, a cluster of conditions that increases the risk for heart disease, diuretics offer greater protection against cardiovascular disease, including heart failure, and are at least as effective for lowering
More: continued here
Tekturna HCT (aliskiren and hydrochlorothiazide) has been approved by the US Food and Drug Administration as a single-tablet combination of two high blood pressure medicines Tekturna (aliskiren), the first new type of high blood pressure medicine in more than a decade, and the diuretic hydrochlorothiazide (HCT)[1].
More: continued here
If you suffer from high blood pressure (hypertension) your genotype may influence how well you respond to certain medications, according to an article in the Journal of the American Medical
More: continued here
Taking vitamins C or E during pregnancy will not reduce a woman’s risk of experiencing pre-eclampsia, a Cochrane Systematic Review has concluded.Pre-eclampsia can occur during pregnancy when a woman develops high blood pressure and tests show that protein is appearing in her urine. The situation can be dangerous to both her health and that of the developing baby. Indeed it is a major cause of death in women worldwide.
More: continued here
Speedel Holding Ltd (SWX: SPPN) announced that it is delighted by the FDA approval of a second product containing SPP100 (aliskiren) in the USA for the treatment of hypertension. The approval was announced by Novartis who is responsible for commercialisation of this first in class direct renin inhibitor.
More: continued here
The early addition of LipitorŪ (atorvastatin calcium) Tablets to effective blood pressure lowering
More: continued here
Scientists have identified the gene that sets off a sequence of events in the blood vessels of otherwise healthy adults that can lead to high blood pressure. The disease process eventually makes conditions in vessels ripe for the creation of blockages that can cause heart attacks, strokes and circulatory problems.
More: continued here
It is a health concern that tens of thousands of Kentuckians battle every day– the struggle to keep their blood pressure in check. Oftentimes, it involves numerous medications and lifestyle changes. In some cases even that combination is not enough, and patients are faced with potentially life-ending consequences. The struggles are real for many people across the Commonwealth. That is why a FDA-approved clinical trial at the UK College of Medicine is so important.
More: continued here
Preeclampsia, a major cause of maternal death and perinatal morbidity, strikes one in 20 pregnancies. Symptoms of preeclampsia include hypertension and proteinuria. Preeclampsia can progress to eclampsia, which is characterized by life-threatening brain seizures and kidney damage in the mother. There are a number of risk factors for the development of preeclampsia such as first pregnancy, diabetes, obesity, hypertension, and the age of the mother.
More: continued here
People who experience brief periods of blocked blood flow may be better conditioned to survive a full-blown heart attack later, according to new research from the University of Cincinnati (UC).In a five-year laboratory study, UC surgeon-scientist Karyn Butler, MD, found that when the heart experiences short periods of stress, either from reduced blood flow or high blood pressure, it activates a protective molecular pathway – known as JAK-STAT – that protects the heart muscle.
More: continued here
